Protein Signatures of NK Cell–Mediated Melanoma Killing Predict Response to Immunotherapies-Reference-Cited by-同舟云学术

Protein Signatures of NK Cell–Mediated Melanoma Killing Predict Response to Immunotherapies

Published:2021-09-13 Issue:21 Volume:81 Page:5540-5554
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Cappello Sabrina^ORCID,Sung Hsu-Min^ORCID,Ickes Christian,Gibhardt Christine S.^ORCID,Vultur Adina^ORCID,Bhat Hilal,Hu Zhongwen,Brafford Patricia,Denger Andreas^ORCID,Stejerean-Todoran Ioana^ORCID,Köhn Rixa-Mareike^ORCID,Lorenz Verena,Künzel Nicolas,Salinas Gabriela,Stanisz Hedwig,Legler Tobias^ORCID,Rehling Peter,Schön Michael P.^ORCID,Lang Karl S.,Helms Volkhard,Herlyn Meenhard,Hoth Markus^ORCID,Kummerow Carsten^ORCID,Bogeski Ivan

Funder

German Research Foundation

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inverse correlation between TP53 gene status and PD-L1 protein levels in a melanoma cell model depends on an IRF1/SOX10 regulatory axis;Cellular & Molecular Biology Letters;2024-09-05

2. Immune Regulation and Immune Therapy in Melanoma: Review with Emphasis on CD155 Signalling;Cancers;2024-05-21

3. TIGIT, a novel immune checkpoint therapy for melanoma;Cell Death & Disease;2023-07-26

4. Innovative breakthroughs facilitated by single-cell multi-omics: manipulating natural killer cell functionality correlates with a novel subcategory of melanoma cells;Frontiers in Immunology;2023-06-26

5. Anticancer traits of chimeric antigen receptors (CARs)-Natural Killer (NK) cells as novel approaches for melanoma treatment;BMC Cancer;2022-11-25